Hinge Health (HNGE) Cash & Equivalents (2023 - 2026)

Hinge Health has disclosed Cash & Equivalents across 4 years of filings, most recently posting $186.7 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $186.7 million, down 35.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $186.7 million (down 35.29% YoY), and the FY2025 annual result was $208.0 million, down 30.85% from the prior year.
• Cash & Equivalents came in at $186.7 million for Q1 2026 at Hinge Health, down from $208.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $300.8 million in Q4 2024 to a low of $186.7 million in Q1 2026.
• The 4-year median for Cash & Equivalents is $235.0 million (2023), against an average of $237.2 million.
• Across the five-year window, Cash & Equivalents rose 28.02% in 2024 and plunged 35.29% in 2026, its largest moves.
• Hinge Health's Cash & Equivalents stood at $235.0 million in 2023, then increased by 28.02% to $300.8 million in 2024, then plunged by 30.85% to $208.0 million in 2025, then dropped by 10.25% to $186.7 million in 2026.
• The last three Cash & Equivalents figures came in at $186.7 million (Q1 2026), $208.0 million (Q4 2025), and $214.0 million (Q3 2025), per Business Quant data.